Geode Capital Management
TGTX icon

Geode Capital Management’s TG Therapeutics TGTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$126M Buy
3,490,457
+207,890
+6% +$7.51M 0.01% 877
2025
Q1
$129M Buy
3,282,567
+89,062
+3% +$3.51M 0.01% 823
2024
Q4
$96.1M Sell
3,193,505
-11,723
-0.4% -$353K 0.01% 1029
2024
Q3
$75M Sell
3,205,228
-1,162
-0% -$27.2K 0.01% 1187
2024
Q2
$57.1M Buy
3,206,390
+98,946
+3% +$1.76M 0.01% 1268
2024
Q1
$47.3M Buy
3,107,444
+10,798
+0.3% +$164K ﹤0.01% 1397
2023
Q4
$52.9M Buy
3,096,646
+162,820
+6% +$2.78M 0.01% 1315
2023
Q3
$24.5M Buy
2,933,826
+103,237
+4% +$863K ﹤0.01% 1692
2023
Q2
$70.3M Buy
2,830,589
+150,789
+6% +$3.75M 0.01% 1010
2023
Q1
$40.3M Buy
2,679,800
+93,527
+4% +$1.41M 0.01% 1340
2022
Q4
$30.6M Buy
2,586,273
+175,834
+7% +$2.08M ﹤0.01% 1484
2022
Q3
$14.3M Buy
2,410,439
+86,835
+4% +$514K ﹤0.01% 1989
2022
Q2
$9.88M Buy
2,323,604
+135,133
+6% +$574K ﹤0.01% 2262
2022
Q1
$20.8M Sell
2,188,471
-121,366
-5% -$1.15M ﹤0.01% 1878
2021
Q4
$43.9M Buy
2,309,837
+7,459
+0.3% +$142K 0.01% 1400
2021
Q3
$76.6M Buy
2,302,378
+145,702
+7% +$4.85M 0.01% 965
2021
Q2
$83.7M Buy
2,156,676
+109,244
+5% +$4.24M 0.01% 905
2021
Q1
$98.7M Buy
2,047,432
+269,045
+15% +$13M 0.02% 763
2020
Q4
$92.5M Buy
1,778,387
+154,545
+10% +$8.04M 0.02% 733
2020
Q3
$43.5M Buy
1,623,842
+123,295
+8% +$3.3M 0.01% 994
2020
Q2
$29.2M Buy
1,500,547
+160,014
+12% +$3.12M 0.01% 1225
2020
Q1
$13.2M Buy
1,340,533
+239,730
+22% +$2.36M ﹤0.01% 1565
2019
Q4
$12.2M Sell
1,100,803
-14,542
-1% -$161K ﹤0.01% 1872
2019
Q3
$6.26M Buy
1,115,345
+80,716
+8% +$453K ﹤0.01% 2249
2019
Q2
$8.95M Buy
1,034,629
+106,480
+11% +$921K ﹤0.01% 2032
2019
Q1
$7.46M Buy
928,149
+172,944
+23% +$1.39M ﹤0.01% 2092
2018
Q4
$3.1M Buy
755,205
+70,398
+10% +$289K ﹤0.01% 2512
2018
Q3
$3.83M Buy
684,807
+95,877
+16% +$537K ﹤0.01% 2531
2018
Q2
$7.74M Buy
588,930
+90,679
+18% +$1.19M ﹤0.01% 2066
2018
Q1
$7.08M Buy
498,251
+35,981
+8% +$511K ﹤0.01% 2017
2017
Q4
$3.79M Buy
462,270
+8,699
+2% +$71.3K ﹤0.01% 2373
2017
Q3
$5.37M Buy
453,571
+22,817
+5% +$270K ﹤0.01% 2165
2017
Q2
$4.33M Buy
430,754
+68,401
+19% +$687K ﹤0.01% 2263
2017
Q1
$4.22M Buy
362,353
+70,751
+24% +$824K ﹤0.01% 2213
2016
Q4
$1.36M Buy
291,602
+9,477
+3% +$44K ﹤0.01% 2845
2016
Q3
$2.18M Buy
282,125
+4,848
+2% +$37.5K ﹤0.01% 2512
2016
Q2
$1.68M Buy
277,277
+158
+0.1% +$957 ﹤0.01% 2590
2016
Q1
$2.36K Buy
277,119
+25,517
+10% +$217 ﹤0.01% 2347
2015
Q4
$3M Buy
251,602
+3,986
+2% +$47.5K ﹤0.01% 2208
2015
Q3
$2.5M Buy
247,616
+2,896
+1% +$29.2K ﹤0.01% 2289
2015
Q2
$4.06M Buy
244,720
+51,022
+26% +$846K ﹤0.01% 2050
2015
Q1
$3M Buy
193,698
+9,812
+5% +$152K ﹤0.01% 2177
2014
Q4
$2.91M Buy
183,886
+7,573
+4% +$120K ﹤0.01% 2173
2014
Q3
$1.88M Buy
176,313
+1,806
+1% +$19.3K ﹤0.01% 2388
2014
Q2
$1.64M Buy
174,507
+22,340
+15% +$210K ﹤0.01% 2509
2014
Q1
$1.05M Buy
152,167
+64,460
+73% +$444K ﹤0.01% 2768
2013
Q4
$342K Buy
87,707
+1,103
+1% +$4.3K ﹤0.01% 3238
2013
Q3
$441K Buy
86,604
+67,814
+361% +$345K ﹤0.01% 3009
2013
Q2
$120K Buy
+18,790
New +$120K ﹤0.01% 3384